2024 Exam Room Guide - 70

Point-of-Care Testing
* Faster access to test results: Help inform
appropriate and targeted treatment decisions
* Improved workflow: The BD Veritor™
Plus
Analyzer improves workflow with an Analyze
Now or Walk Away mode, providing test results
(with a print-enabled function) and aiding in
decision-making while the patient is on site
* Improved traceability: The BD Veritor™
InfoScan
module can scan 3 different identifiers (operator
ID, specimen ID, and test kit/lot) that can be
locally recorded, printed, or downloaded, and
reduces hands-on time through automated
documentation
BD Veritor™
Plus System
The wireless BD Veritor™
Plus System provides
health-care providers and laboratorians in
physician offices, clinics, hospitals, and integrated
delivery networks (IDNs) with objective, lab-quality
immunoassay test results within minutes. This fast
and accurate solution streamlines the point-of-care
(POC) diagnostic workflow and allows providers to
quickly review patient results and determine the
appropriate treatment in a single consultation. The
new system can help detect infectious diseases
such as influenza A and B, respiratory syncytial
virus (RSV), and group A strep while the patient
is still on site, which can enable faster decisionmaking
for an earlier intervention opportunity.
* Modularity: Provides a unique solution to meet
each testing site's preference
* Connectivity: BD Veritor™
InfoSync module
provides the same benefits as BD Veritor™
InfoScan. Connects and documents tests results
across multiple sites and can integrate with a
hospital electronic medical record or laboratory
information system
* Advanced particle technology: Enhances
sensitivity by using a proprietary process to
produce highly stable, modified colloidal metal
particles.
* Adaptive read technology: Compensates for
background. Nonspecific binding helps improve
specificity to reduce false-positive results
#256066, Veritor Plus Analyzer
(126-5527)........................................................................ea
Acucy™
The Acucy™
System
Influenza A&B Test on the Acucy™
System provides clinicians flexibility in workflow
and accurate, standardized results for improved
patient care.
* CLIA waived
* " Read Now " or " Walk Away " modes
* Results within 15 minutes
* Nasal and nasopharyngeal swab types
* Includes 2 additional tests for quality-control
testing
#1039, Acucy Reader System
(136-8725)........................................................................ea
#1010, Acucy Influenza A & B Test
(136-8722)........................................................................ea
Code: Influenza A: 87804QW†, Influenza B: 87804-59†
CPT®
DIGIVAL™
Sofia®
Accurately reads and interprets lateral flow tests
in just seconds, delivering automated, objective
results in any health-care setting. It is a camerabased
instrument that will detect the presence
of and identify a completed lateral flow assay,
analyze the intensity of the test and control line,
and display the results (positive, negative, or
invalid) on the color touch-screen.
* Small footprint
* 4.3 " color touch-screen
* Barcode scanner and optional printer
* QC lockout features
* Workflow flexibility
* ReadNOW or Walkaway capabilities
* Data storage: 1000 patient test results
* 100 QC test results
* 50 calibration check test results
* Accurate, objective, rapid results
* Bidirectional connectivity
(131-0547).........................................................................ea
#LFR-124, DIGIVAL Reader
(132-8754)........................................................................ ea
(131-0546)................................................................22/box
#MCP1810395, Thermal Printer
Influenza A&B Card 2
#575000, BinaxNow™
Influenza A+B FIA Test
This CLIA-waived test uses advanced
immunofluorescence-based lateral-flow technology
to detect influenza A and B viral nucleoprotein
antigens in nasal and nasopharyngeal swab and
nasopharyngeal aspirate/wash specimens taken
directly from symptomatic patients.
* Enhanced assay sensitivity
* Results in 15 minutes
* Accurate detection with nasal swab, NP swab
and NPA/wash samples
* Nasal swab sensitivity (A/B): 90%/89%; specificity
(A/B): 95%/96%
* NP swab sensitivity (A/B): 97%/90%; specificity
(A/B): 95%/97%
* NPA/wash sensitivity (A/B): 99%/88%; specificity
(A/B): 96%/96%
* Room temperature storage
* 21-month shelf life from date of manufacture
* For use with Sofia Analyzer (sold separately)
* CLIA-waived for nasal and nasopharyngeal
swabs
#20299, Sofia 2 Analyzer
(128-5292)........................................................................ea
#20218, Sofia Influenza A+B Test
(122-4092)...............................................................25/box
CPT®
www.henryschein.com/medical
Codes: Influenza A: 87804QW†; Influenza B: 87804-59†
70
BD Veritor™
Test Kit
System Flu A+B
The first CLIA-waived flu A+B test referenced
against PCR, a higher sensitivity standard than
culture. Device is ready to insert into reader 10
minutes after sample is added.
* Positive percent agreement (A/B): 82.1%/74.6%
* Negative percent agreement (A/B): 98.6%/99.6%
* Positive agreement vs. PCR for current visual
read rapid tests ranges from 10% to 70%
* Streamlined workflow: Provides a digital result in
<11 minutes, with <50 seconds of hands-on time
#256045
(992-0002)..............................................................30/box
CPT®
Codes: Influenza A: 87804QW† / Influenza B: 87804-59†; Using
the Objective and Differentiated Reader System: 87999†
24MS2626
2024 Exam Room Guide

Table of Contents for the Digital Edition of 2024 Exam Room Guide
